NM_001387283.1:c.4913A>G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_001387283.1(SMARCA4):​c.4913A>G​(p.Gln1638Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000264 in 1,400,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1638H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

SMARCA4
NM_001387283.1 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:1

Conservation

PhyloP100: 1.09

Publications

1 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • otosclerosis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08920765).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000264 (37/1400658) while in subpopulation NFE AF = 0.0000333 (36/1079880). AF 95% confidence interval is 0.0000244. There are 0 homozygotes in GnomAdExome4. There are 17 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001387283.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
NM_001387283.1
MANE Plus Clinical
c.4913A>Gp.Gln1638Arg
missense
Exon 35 of 36NP_001374212.1Q9HBD4
SMARCA4
NM_003072.5
MANE Select
c.4817A>Gp.Gln1606Arg
missense
Exon 34 of 35NP_003063.2
SMARCA4
NM_001128849.3
c.4913A>Gp.Gln1638Arg
missense
Exon 35 of 36NP_001122321.1Q9HBD4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
ENST00000646693.2
MANE Plus Clinical
c.4913A>Gp.Gln1638Arg
missense
Exon 35 of 36ENSP00000495368.1Q9HBD4
SMARCA4
ENST00000344626.10
TSL:1 MANE Select
c.4817A>Gp.Gln1606Arg
missense
Exon 34 of 35ENSP00000343896.4P51532-1
SMARCA4
ENST00000643549.1
c.4823A>Gp.Gln1608Arg
missense
Exon 34 of 35ENSP00000493975.1A0A2R8Y4P4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000128
AC:
2
AN:
156396
AF XY:
0.0000242
show subpopulations
Gnomad AFR exome
AF:
0.000118
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000165
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000264
AC:
37
AN:
1400658
Hom.:
0
Cov.:
33
AF XY:
0.0000246
AC XY:
17
AN XY:
691010
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31632
American (AMR)
AF:
0.00
AC:
0
AN:
35786
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35802
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79402
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49220
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5686
European-Non Finnish (NFE)
AF:
0.0000333
AC:
36
AN:
1079880
Other (OTH)
AF:
0.0000172
AC:
1
AN:
58070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Rhabdoid tumor predisposition syndrome 2 (3)
-
2
-
not provided (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
Intellectual disability, autosomal dominant 16 (1)
-
1
-
Rhabdoid tumor predisposition syndrome 2;C3553249:Intellectual disability, autosomal dominant 16 (1)
-
1
-
Rhabdoid tumor predisposition syndrome 2;C3553249:Intellectual disability, autosomal dominant 16;C5935610:Otosclerosis 12 (1)
-
1
-
SMARCA4-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.86
D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.089
T
MetaSVM
Benign
-0.38
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.28
N
REVEL
Benign
0.17
Sift
Benign
0.51
T
Sift4G
Benign
0.75
T
Polyphen
0.097
B
Vest4
0.062
MutPred
0.14
Gain of methylation at R1640 (P = 0.0508)
MVP
0.60
MPC
1.1
ClinPred
0.11
T
GERP RS
4.6
Varity_R
0.15
gMVP
0.57
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878854231; hg19: chr19-11170769; API